Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.

被引：0
|
作者：
Rizzoli, R
Roux, C
Greenspan, S
Bone, H
Schnitzer, T
Watts, N
Adami, S
Uebelhart, B
Peverly, C
Kaur, A
Wu, M
Orloff, J
Santora, A
机构：
[1] Univ Geneva, Hop Cantonal, CH-1211 Geneva, Switzerland
[2] Hop Cochin, F-75674 Paris, France
[3] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[4] Michigan Bone Clin, Detroit, MI USA
[5] Northwestern Univ, Chicago, IL 60611 USA
[6] Emory Univ, Atlanta, GA 30322 USA
[7] Univ Verona, I-37100 Verona, Italy
[8] Merck Res Labs, Rahway, NJ USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S527 / S527
页数：1
相关论文
共 50 条
  • [11] Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis (vol 20, pg 2031, 2004)
    Sebba, AI
    Bonnick, SL
    Kagan, R
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (02) : 325 - 325
  • [12] Once-weekly alendronate: Two-year subgroup efficacy analyses in postmenopausal women with osteoporosis
    Bone, H
    Felsenberg, D
    Greenwald, M
    Schnitzer, T
    Kaur, A
    Peverly, C
    Cudny, M
    Orloff, J
    Santora, A
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S30 - S30
  • [13] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S44
  • [14] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Melton, M
    Lewiecki, EM
    Rosen, R
    Bockman, RS
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S36 - S36
  • [15] TREATMENT WITH ONCE-WEEKLY ALENDRONATE 70 MG COMPARED TO ONCE-WEEKLY RISEDRONATE 35 MG IN WOMEN WITH POSTMENOPAUSALE OSTEOPOROSIS: A RANDOMIZED DOUBLE-BLIND STUDY
    Pietschmann, Peter
    JOURNAL FUR MINERALSTOFFWECHSEL, 2005, 12 (01): : 36 - 38
  • [16] Efficacy of alendronate 70mg once-weekly in postmenopausal Chinese women with osteopororis
    Ho, AYY
    Kung, AWC
    BONE, 2003, 32 (05) : S206 - S206
  • [17] Alendronate 35mg once-weekly treatment increased bone mineral density in Japanese patients with osteoporosis.
    Uchida, S
    Taniguchi, T
    Shimizu, T
    Kakikawa, T
    Okuyama, K
    Okaniwa, M
    Arizono, H
    Nagata, K
    Santora, A
    Shiraki, M
    Fukunaga, M
    Tomomitsu, T
    Ohashi, Y
    Nakamura, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S278 - S279
  • [18] Safety of once-weekly alendronate 70 mg in periodontal disease
    Van Dyke, T
    Ryder, M
    Cordero, R
    Gallagher, A
    Griffiths, G
    Offenbacher, S
    Cizza, G
    Kimberlin, M
    Lombardi, A
    Meng, L
    Shih, W
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 26 - 26
  • [19] Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Mako, B
    Smith, ME
    Yates, J
    Palmisano, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S405 - S405
  • [20] Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.
    Palmisano, J
    Melton, M
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S24 - S24
12345